Viral skin-care hacks and products are so plentiful that it's almost impossible to discern which ones are actually worth your ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device ... (reduction of 2.6 versus 0.9 ...
The Business Research Company's Infusion Therapy Devices Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, February 25 ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations ...
2025 – The FDA has approved a new wearable device for adults with advanced Parkinson ... After 12 weeks, Onapgo reduced daily "off" time by 2.6 hours and increased "on" time by 2.8 hours ...
From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton ...
6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果